Skip Navigation

Cardiovascular Research 1997 35(1):138-147; doi:10.1016/S0008-6363(97)00097-7
© 1997 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Sun, Y.
Right arrow Articles by Weber, K. T
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sun, Y.
Right arrow Articles by Weber, K. T
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 1997, European Society of Cardiology

Fibrosis of atria and great vessels in response to angiotensin II or aldosterone infusion

Yao Sun*, Felix J.A Ramires and Karl T Weber

Division of Cardiology, Department of Internal Medicine, University of Missouri Health Sciences Center, MA432 Medical Sciences Building, Columbia, MO 65212, USA

* Corresponding author. Tel.: +1 (573) 882-8580; fax: +1 (573) 884-4691.

Objective: Myocardial fibrosis, associated with increased expression of angiotensin converting enzyme (ACE) and bradykinin (BK) receptor binding at sites of tissue repair, accompanies chronic elevations in circulating angiotensin II (AngII) and/or aldosterone (ALDO) that simulate chronic cardiac failure. A role for increased ventricular wall stress, associated with arterial hypertension, that can accompany such neurohormonal activation when ventricular function is not compromised, has been held responsible for this structural remodeling. To address this proposition, we monitored morphology of right and left atria and pulmonary artery, where stress is not increased, and compared these structures with hypertensive aorta. Methods: Experimental groups included: (1) unoperated and untreated controls; (2) intact rats receiving AngII (9 µg/h) for 2 weeks and which causes arterial hypertension; (3) uninephrectomized control rats on a high sodium diet for 6 weeks; and (4) uninephrectomized rats receiving ALDO (0.75 µg/h) and a high sodium diet for 6 weeks and which results in gradual onset arterial hypertension. Fibrosis was identified by light microscopy in sections stained with collagen specific picrosirius red, while ACE, AngII and BK receptor binding were localized and quantitated by in vitro autoradiography using 125I-351A, 125I[Sar1,Ile8]AngII, and 125I[Tyr8]BK, respectively. AngII receptor subtype was defined by the presence of excess AT1 (losartan) or AT2 (PD123177) receptor antagonists, respectively. Results: With either AngII or ALDO administration, and compared to controls, we found: (1) microscopic scarring that replaced lost myocytes in both left and right atria; (2) an increase in adventitial collagen of both pulmonary artery and aorta (perivascular fibrosis); (3) markedly increased ACE binding at fibrous tissue sites in both atria and great vessels; (4) unchanged atrial and great vessel AT1 receptor binding; and (5) significantly increased BK receptor binding at sites of atrial and perivascular fibrosis. Conclusions: Thus, the appearance of atrial fibrosis and perivascular fibrosis of aorta and pulmonary artery, together with associated increase in ACE and BK receptor binding, in rats receiving AngII or ALDO suggests these responses are not related to altered ventricular wall stress or arterial hypertension, but rather to these effector hormones of the circulating renin–angiotensin–aldosterone system. Local BK, regulated by ACE found in fibrous tissue and BK receptor binding may play a role in structural remodeling of atria and great vessels in these rat models that simulate chronic cardiac failure.

KEYWORDS Fibrosis; Angiotensin receptor; Angiotensin converting enzyme; Autoradiography, in vitro; Bradykinin receptors


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Exp PhysiolHome page
B. Martin-Fernandez, M.ķa Miana, N. De las Heras, G. Ruiz-Hurtado, M.ķa Fernandez-Velasco, M. Bas, S. Ballesteros, V. Lahera, V. Cachofeiro, and C. Delgado
Cardiac L-type calcium current is increased in a model of hyperaldosteronism in the rat
Exp Physiol, June 1, 2009; 94(6): 675 - 683.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
K. T. Weber, W. B. Weglicki, and R. U. Simpson
Macro- and micronutrient dyshomeostasis in the adverse structural remodelling of myocardium
Cardiovasc Res, February 15, 2009; 81(3): 500 - 508.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
B. P. Shapiro, T. E. Owan, S. Mohammed, M. Kruger, W. A. Linke, J. C. Burnett Jr, and M. M. Redfield
Mineralocorticoid Signaling in Transition to Heart Failure With Normal Ejection Fraction
Hypertension, February 1, 2008; 51(2): 289 - 295.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
B. Pitt and G. S. Pitt
Added Benefit of Mineralocorticoid Receptor Blockade in the Primary Prevention of Sudden Cardiac Death
Circulation, June 12, 2007; 115(23): 2976 - 2982.
[Full Text] [PDF]


Home page
HypertensionHome page
S. C.M. Choisy, L. A. Arberry, J. C. Hancox, and A. F. James
Increased Susceptibility to Atrial Tachyarrhythmia in Spontaneously Hypertensive Rat Hearts
Hypertension, March 1, 2007; 49(3): 498 - 505.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. D. Crowley, S. B. Gurley, M. J. Herrera, P. Ruiz, R. Griffiths, A. P. Kumar, H.-S. Kim, O. Smithies, T. H. Le, and T. M. Coffman
Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney
PNAS, November 21, 2006; 103(47): 17985 - 17990.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J.-H. Parmentier, C. Zhang, A. Estes, S. Schaefer, and K. U. Malik
Essential role of PKC-{zeta} in normal and angiotensin II-accelerated neointimal growth after vascular injury
Am J Physiol Heart Circ Physiol, October 1, 2006; 291(4): H1602 - H1613.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
A. Turchin, C. Z. Guo, G. K. Adler, V. Ricchiuti, I. S. Kohane, and G. H. Williams
Effect of Acute Aldosterone Administration on Gene Expression Profile in the Heart
Endocrinology, July 1, 2006; 147(7): 3183 - 3189.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
T.-C. E. Lin, S.-C. Chien, P.-C. Hsu, and L.-A. Li
Mechanistic Study of Polychlorinated Biphenyl 126-Induced CYP11B1 and CYP11B2 Up-Regulation
Endocrinology, March 1, 2006; 147(3): 1536 - 1544.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. Vidal, Y. Sun, S. K. Bhattacharya, R. A. Ahokas, I. C. Gerling, and K. T. Weber
Calcium paradox of aldosteronism and the role of the parathyroid glands
Am J Physiol Heart Circ Physiol, January 1, 2006; 290(1): H286 - H294.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
R. T. Cowling, X. Zhang, V. C. Reese, M. Iwata, D. Gurantz, W. H. Dillmann, and B. H. Greenberg
Effects of cytokine treatment on angiotensin II type 1A receptor transcription and splicing in rat cardiac fibroblasts
Am J Physiol Heart Circ Physiol, September 1, 2005; 289(3): H1176 - H1183.
[Abstract] [Full Text] [PDF]


Home page
J Clin PharmacolHome page
W. R. Ravis, S. Reid, D. A. Sica, and D. S. Tolbert
Pharmacokinetics of Eplerenone After Single and Multiple Dosing in Subjects With and Without Renal Impairment
J. Clin. Pharmacol., July 1, 2005; 45(7): 810 - 821.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
I. Z. Jaffe and M. E. Mendelsohn
Angiotensin II and Aldosterone Regulate Gene Transcription Via Functional Mineralocortocoid Receptors in Human Coronary Artery Smooth Muscle Cells
Circ. Res., April 1, 2005; 96(6): 643 - 650.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
V. S. Chhokar, Y. Sun, S. K. Bhattacharya, R. A. Ahokas, L. K. Myers, Z. Xing, R. A. Smith, I. C. Gerling, and K. T. Weber
Hyperparathyroidism and the Calcium Paradox of Aldosteronism
Circulation, February 22, 2005; 111(7): 871 - 878.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
K. T. Weber
From Inflammation to Fibrosis: A Stiff Stretch of Highway
Hypertension, April 1, 2004; 43(4): 716 - 719.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
A. D Struthers and T. M MacDonald
Review of aldosterone- and angiotensin II-induced target organ damage and prevention
Cardiovasc Res, March 1, 2004; 61(4): 663 - 670.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
A. Khan, G. W. Moe, N. Nili, E. Rezaei, M. Eskandarian, J. Butany, and B. H. Strauss
The cardiac atria are chambers of active remodeling and dynamic collagen turnover during evolving heart failure
J. Am. Coll. Cardiol., January 7, 2004; 43(1): 68 - 76.
[Abstract] [Full Text] [PDF]


Home page
Journal of Renin-Angiotensin-Aldosterone SystemHome page
A. Nap, C. N. Belterman, M.-J. Mathy, J. C Balt, M. Pfaffendorf, and P. A van Zwieten
Impaired neuronal and vascular responses to angiotensin II in a rabbit congestive heart failure model
Journal of Renin-Angiotensin-Aldosterone System, December 1, 2003; 4(4): 220 - 227.
[Abstract] [PDF]


Home page
Circ. Res.Home page
R. A. Ahokas, K. J. Warrington, I. C. Gerling, Y. Sun, L. A. Wodi, P. A. Herring, L. Lu, S. K. Bhattacharya, A. E. Postlethwaite, and K. T. Weber
Aldosteronism and Peripheral Blood Mononuclear Cell Activation: A Neuroendocrine-Immune Interface
Circ. Res., November 14, 2003; 93 (10): e124 - e135.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
C. S. Cook, L. M. Berry, R. H. Bible, J. D. Hribar, E. Hajdu, and N. W. Liu
PHARMACOKINETICS AND METABOLISM OF [14C]EPLERENONE AFTER ORAL ADMINISTRATION TO HUMANS
Drug Metab. Dispos., November 1, 2003; 31(11): 1448 - 1455.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
I. C. Gerling, Y. Sun, R. A. Ahokas, L. A. Wodi, S. K. Bhattacharya, K. J. Warrington, A. E. Postlethwaite, and K. T. Weber
Aldosteronism: an immunostimulatory state precedes proinflammatory/fibrogenic cardiac phenotype
Am J Physiol Heart Circ Physiol, July 11, 2003; 285(2): H813 - H821.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
W. Qin, A. E. Rudolph, B. R. Bond, R. Rocha, E. A.G. Blomme, J. J. Goellner, J. W. Funder, and E. G. McMahon
Transgenic Model of Aldosterone-Driven Cardiac Hypertrophy and Heart Failure
Circ. Res., July 11, 2003; 93(1): 69 - 76.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
C. S. Cook, L. M. Berry, D. H. Kim, E. G. Burton, J. D. Hribar, and L. Zhang
Involvement of CYP3A in the Metabolism of Eplerenone in Humans and Dogs: Differential Metabolism by CYP3A4 and CYP3A5
Drug Metab. Dispos., December 1, 2002; 30(12): 1344 - 1351.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. Lacolley, C. Labat, A. Pujol, C. Delcayre, A. Benetos, and M. Safar
Increased Carotid Wall Elastic Modulus and Fibronectin in Aldosterone-Salt-Treated Rats: Effects of Eplerenone
Circulation, November 26, 2002; 106(22): 2848 - 2853.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
Y. Sun, J. Zhang, L. Lu, S. S. Chen, M. T. Quinn, and K. T. Weber
Aldosterone-Induced Inflammation in the Rat Heart : Role of Oxidative Stress
Am. J. Pathol., November 1, 2002; 161(5): 1773 - 1781.
[Abstract] [Full Text] [PDF]


Home page
Journal of Renin-Angiotensin-Aldosterone SystemHome page
P. Gunaruwan, M. Schmitt, J. Taylor, L. Lee, A. Struthers, and M. Frenneaux
Lack of rapid aldosterone effects on forearm resistance vasculature in health
Journal of Renin-Angiotensin-Aldosterone System, June 1, 2002; 3(2): 123 - 125.
[Abstract] [PDF]


Home page
NEJMHome page
K. T. Weber
Aldosterone in Congestive Heart Failure
N. Engl. J. Med., December 6, 2001; 345(23): 1689 - 1697.
[Full Text] [PDF]


Home page
Journal of Renin-Angiotensin-Aldosterone SystemHome page
V. V Petrov, R. H Fagard, and P. J Lijnen
Transforming growth factor-{beta}1 induces angiotensin-converting enzyme synthesis in rat cardiac fibroblasts during their differentiation to myofibroblasts
Journal of Renin-Angiotensin-Aldosterone System, December 1, 2000; 1(4): 342 - 352.
[Abstract] [PDF]


Home page
Arch Intern MedHome page
E. Grossman, F. H. Messerli, and J. M. Neutel
Angiotensin II Receptor Blockers: Equal or Preferred Substitutes for ACE Inhibitors?
Arch Intern Med, July 10, 2000; 160(13): 1905 - 1911.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
H. P. Brunner-La Rocca, G. Vaddadi, and M. D. Esler
Recent insight into therapy of congestive heart failure: focus on ACE inhibition and angiotensin-II antagonism
J. Am. Coll. Cardiol., April 1, 1999; 33(5): 1163 - 1173.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
R. Rocha, P. N. Chander, A. Zuckerman, and C. T. Stier Jr.
Role of Aldosterone in Renal Vascular Injury in Stroke-Prone Hypertensive Rats
Hypertension, January 1, 1999; 33(1): 232 - 237.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. E. McEwan, G. A. Gray, L. Sherry, D. J. Webb, and C. J. Kenyon
Differential Effects of Angiotensin II on Cardiac Cell Proliferation and Intramyocardial Perivascular Fibrosis In Vivo
Circulation, December 15, 1998; 98(24): 2765 - 2773.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. Hafizi, J. Wharton, K. Morgan, S. P. Allen, A. H. Chester, J. D. Catravas, J. M. Polak, and M. H. Yacoub
Expression of Functional Angiotensin-Converting Enzyme and AT1 Receptors in Cultured Human Cardiac Fibroblasts
Circulation, December 8, 1998; 98(23): 2553 - 2559.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
K. T. Weber
Extracellular Matrix Remodeling in Heart Failure : A Role for De Novo Angiotensin II Generation
Circulation, December 2, 1997; 96(11): 4065 - 4082.
[Full Text]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.